Recently published research conducted by the National Pharmaceutical Council, PQA and the University of Rhode Island measured the impact of patient nonadherence to oral anticancer medications. The study findings have been published in the Journal of Managed Care & Specialty Pharmacy.
The PQA Postdoctoral Executive Fellowship helps produce the next generation of leaders in health care quality through a full-time, 12-month program. Executive Fellows collaborate with PQA staff, members and other stakeholders on a variety of initiatives to improve medication use quality. During the fellowship, individuals will expand their skills and experience in project management, quality measure design and implementation, non-profit administration and association management, and health care quality research.
Biopharmaceutical innovation has led to an increase in the availability of oral medications to treat cancer. Oral anticancer medications (OAMs) are much more convenient for patients and avoid the inconvenience and administration costs of having to receive treatment at a doctor’s office or outpatient infusion center, allowing patients to self-administer oral medication at home. One challenge with OAMs however is nonadherence. Research has shown that almost half of patients on OAMs do not take their medications as prescribed.
PQA’s Board of Directors represents a diverse group of thought leaders and experts in healthcare, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA's Board members.
Each month PQA hosts a Quality Forum Webinar which focuses on best practices and emerging trends in medication use quality, medication services and other initiatives that can improve health care quality.
PQA provides healthcare quality experience to students from a wide variety of disciplines. This summer, we are hosting three students through our PQA Summer Executive Internship sponsored by Pharmacy Quality Solutions and MPH practicum program.
This guest blog is one in a series by sponsors of the 2022 PQA Annual Meeting on the application of measures into daily practice. The views shared in this series are those of the author and do not reflect any PQA positions
At PQA, our research develops evidence to support meaningful quality measures, demonstrates the value of medications and pharmacist-provided care, and fosters collaboration within the healthcare system to address social determinants of health (SDOH) and improve medication access.
The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.
PQA’s Board of Directors represents a diverse group of thought leaders and experts in healthcare, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA's Board members.
Healthcare providers increasingly recognize the importance of social determinants of health (SDOH). PQA is exploring the role of pharmacists and pharmacy services in addressing patients’ SDOH, including SDOH screenings and additional services that address barriers to medication access and increase medication adherence. Although there is a growing focus on SDOH in healthcare, there is little information on how organizations collect and use SDOH data to support patient care and outcomes.
This past January, PQA published the first edition of the PQA Social Determinants of Health Resource Guide. The guide features 20 real-world SDOH services that are promising for improving the quality and safety of medication use.
PQA, the UNC Eshelman School of Pharmacy and Janssen Scientific Affairs have collaborated to jointly host a "Postdoctoral Fellowship in Real World Evidence, Population Health, and Quality Research." The two-year fellowship aims to prepare an individual for a career in healthcare quality-related outcomes research.
Pharmacists and pharmacy teams are an essential part of the health care delivery system. As pharmacies expand patient services, they need tools to demonstrate their value.
PQA follows a systematic, transparent and consensus-based development process to ensure that measures are important, scientifically acceptable, feasible and usable. This approach produces strong, consistent results, but it also takes time.
PQA is a non-profit organization with 250 diverse members across healthcare. Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.
A comprehensive medication review (CMR) is a medication therapy management (MTM) service designed to systematically collect and assess patient medication information and identify medication therapy problems (MTPs) to develop a care plan for resolution. To ensure Medicare Part D plans are actively engaging in annual CMRs, the Centers for Medicare & Medicaid Services (CMS) added the PQA measure, Completion Rate for CMR, to the Medicare Part D Star Ratings Program. This measure assesses the annual percentage of completed CMRs for eligible beneficiaries.
In a new Population Health Management article, PQA’s Melissa Castora-Binkley, Lisa Hines and I explain how medication adherence quality measures are relevant and high-impact.
PQA’s talented staff is dedicated to improving medication safety, adherence and appropriate use. As experts in measure development, research, education and convening, they lead the implementation of PQA’s quality initiatives to support better medication use and high-quality care. This blog is one in a series profiling PQA's staff.
The 2022 PQA Annual Meeting poster session featured 24 quality improvement and research projects. Sponsored by Pharmacy Quality Solutions, the session provided an opportunity for authors to showcase their work and for attendees to engage in insightful dialogue about health care quality.
